Terms: = Liver cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
2109 results:
1. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract] [Full Text] [Related]
3. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
[TBL] [Abstract] [Full Text] [Related]
4. [Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated pi3k/Akt/FoxO3a signaling pathway].
Zhou JQ; Li HJ; Zeng YH; Chen HH; Liang WY; Zhang J; Ding FP
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1327-1334. PubMed ID: 38621980
[TBL] [Abstract] [Full Text] [Related]
5. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma.
Tang S; Chen H
J Environ Pathol Toxicol Oncol; 2024; 43(3):51-67. PubMed ID: 38608145
[TBL] [Abstract] [Full Text] [Related]
7. Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma.
Raghav A; Jeong GB
Cells; 2024 Apr; 13(7):. PubMed ID: 38607076
[TBL] [Abstract] [Full Text] [Related]
8. Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.
Baek M; Kim M; Choi HI; Binas B; Cha J; Jung KH; Choi S; Chai YG
PLoS One; 2024; 19(4):e0301663. PubMed ID: 38603701
[TBL] [Abstract] [Full Text] [Related]
9. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
10.
Miao X; Jiang P; Zhang X; Li X; Wu Z; Jiang Y; Liu H; Xie W; Li X; Shi B; Cai J; Gong W
Microbiol Spectr; 2024 May; 12(5):e0183923. PubMed ID: 38564670
[TBL] [Abstract] [Full Text] [Related]
11. Sorcin promotes proliferation of hepatocellular carcinoma by regulating VEGFA/B via pi3k pathway.
Zhang H; Hu S; Sanches JGP; Li Y; Wei Y; Pu C; Zhang J
J Physiol Biochem; 2024 May; 80(2):381-392. PubMed ID: 38536659
[TBL] [Abstract] [Full Text] [Related]
12. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
13. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
[TBL] [Abstract] [Full Text] [Related]
14. Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.
Guo BL; Zheng QX; Jiang YS; Zhan Y; Huang WJ; Chen ZY
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2050. PubMed ID: 38517478
[TBL] [Abstract] [Full Text] [Related]
15. Current landscape of preoperative neoadjuvant therapies for initial resectable colorectal cancer liver metastasis.
Cheng XF; Zhao F; Chen D; Liu FL
World J Gastroenterol; 2024 Feb; 30(7):663-672. PubMed ID: 38515943
[TBL] [Abstract] [Full Text] [Related]
16. Evidence of promoting effects of 6:2 Cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health?
Hong J; Du K; Jin H; Chen Y; Jiang Y; Zhang W; Chen D; Zheng S; Cao L
Environ Int; 2024 Apr; 186():108582. PubMed ID: 38513556
[TBL] [Abstract] [Full Text] [Related]
17. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
18. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
19. Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through pi3k/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation.
Wei J; Zhao X; Long F; Tian K; Wu L
Gene; 2024 Jun; 912():148383. PubMed ID: 38493972
[TBL] [Abstract] [Full Text] [Related]
20. A novel pan-pi3k inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation.
Peng X; Huang X; Lulu TB; Jia W; Zhang S; Cohen L; Huang S; Fan J; Chen X; Liu S; Wang Y; Wang K; Isoyama S; Dan S; Wang F; Zhang Z; Elkabets M; Kong D
Mol Cancer; 2024 Mar; 23(1):54. PubMed ID: 38486218
[TBL] [Abstract] [Full Text] [Related]
[Next]
